Cargando…

The Disturbance of Gaze in Progressive Supranuclear Palsy: Implications for Pathogenesis

Progressive supranuclear palsy (PSP) is a disease of later life that is currently regarded as a form of neurodegenerative tauopathy. Disturbance of gaze is a cardinal clinical feature of PSP that often helps clinicians to establish the diagnosis. Since the neurobiology of gaze control is now well un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Athena L., Riley, David E., King, Susan A., Joshi, Anand C., Serra, Alessandro, Liao, Ke, Cohen, Mark L., Otero-Millan, Jorge, Martinez-Conde, Susana, Strupp, Michael, Leigh, R. John
Formato:	Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2010
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008928/ https://www.ncbi.nlm.nih.gov/pubmed/21188269 http://dx.doi.org/10.3389/fneur.2010.00147

Ejemplares similares

Case report: Saccadic ping-pong gaze in progressive supranuclear palsy with predominant postural instability
por: Nunomura, Hikari, et al.
Publicado: (2023)

Gene-Environment Interactions in Progressive Supranuclear Palsy
por: Litvan, Irene, et al.
Publicado: (2021)

Frontrunner in Translation: Progressive Supranuclear Palsy
por: Shoeibi, Ali, et al.
Publicado: (2019)

Clinical Approach to Supranuclear Brainstem Saccadic Gaze Palsies
por: Lloyd-Smith Sequeira, Alexandra, et al.
Publicado: (2017)

Gait Analysis in Progressive Supranuclear Palsy Phenotypes
por: Picillo, Marina, et al.
Publicado: (2021)

Perspective: Balance Assessments in Progressive Supranuclear Palsy: Lessons Learned
por: Dale, Marian L., et al.
Publicado: (2022)

Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors
por: Oyeka, Michelle, et al.
Publicado: (2021)

‘Hummingbird’ sign in progressive supranuclear palsy
por: Shukla, Rakesh, et al.
Publicado: (2009)

Bilateral, vertical supranuclear gaze palsy following unilateral midbrain infarct
por: Yang, Yunfei, et al.
Publicado: (2020)

Enablers to Exercise Participation in Progressive Supranuclear Palsy: Health Professional Perspectives
por: Morris, Meg E., et al.
Publicado: (2021)

A case of Gerstmann-Straussler-Scheinker (GSS) disease with supranuclear gaze palsy
por: Ufkes, Nicole A., et al.
Publicado: (2019)

Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy
por: Picillo, Marina, et al.
Publicado: (2020)

Differentiating Progressive Supranuclear Palsy and Parkinson's Disease With Head-Mounted Displays
por: Herwig, Arvid, et al.
Publicado: (2021)

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
por: Viscidi, Emma, et al.
Publicado: (2021)

The Application of Deep Brain Stimulation for Progressive Supranuclear Palsy: A Systematic Review
por: Wen, Yafei, et al.
Publicado: (2022)

Factors that impact dysphagia and discontinuance of oral intake in patients with progressive supranuclear palsy
por: Iwashita, Yuki, et al.
Publicado: (2023)

Severity of Downgaze Palsy in the Context of Disease Duration Could Estimate Survival Duration in Patients With Progressive Supranuclear Palsy
por: Xie, Tao, et al.
Publicado: (2021)

Balance and gait in progressive supranuclear palsy: a narrative review of objective metrics and exercise interventions
por: Dale, Marian L., et al.
Publicado: (2023)

Caregiver strain in progressive supranuclear palsy and corticobasal syndromes
por: Kellermair, Lukas, et al.
Publicado: (2021)

Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans
por: Kelley, Kristen D., et al.
Publicado: (2018)

Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy
por: Carpinelli, Sandra, et al.
Publicado: (2021)

Genotype–Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities
por: Ruiz-Barrio, Iñigo, et al.
Publicado: (2022)

Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy
por: Kwasny, Mary J., et al.
Publicado: (2021)

Effect of therapeutic exercise on the balance of patients with progressive supranuclear palsy: A pilot study
por: Matsuda, Naomi, et al.
Publicado: (2022)

Behind the Mask of Parkinsonism: A Case Report and Literature Review on Progressive Supranuclear Palsy
por: Asbeutah, Saad, et al.
Publicado: (2023)

MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP–parkinsonism
por: Quattrone, Aldo, et al.
Publicado: (2016)

Progressive Supranuclear Gaze Palsy with Predominant Cerebellar Ataxia: A Case Series with Videos
por: Xu, Zheyu, et al.
Publicado: (2017)

Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes
por: Campagnolo, Marta, et al.
Publicado: (2023)

Frequency and imaging correlates of neuropsychiatric symptoms in Progressive Supranuclear Palsy
por: Cuoco, Sofia, et al.
Publicado: (2023)

Utility of Multi-Modal MRI for Differentiating of Parkinson's Disease and Progressive Supranuclear Palsy Using Machine Learning
por: Talai, Aron S., et al.
Publicado: (2021)

A Home-Based, Music-Cued Movement Program Is Feasible and May Improve Gait in Progressive Supranuclear Palsy
por: Wittwer, Joanne E., et al.
Publicado: (2019)

The Burden of Progressive Supranuclear Palsy on Patients, Caregivers, and Healthcare Systems by PSP Phenotype: A Cross-Sectional Study
por: Pillas, Demetris, et al.
Publicado: (2022)

Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy
por: Hu, Wen-Zheng, et al.
Publicado: (2023)

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
por: Bluett, Brent, et al.
Publicado: (2021)

Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)
por: Alster, Piotr, et al.
Publicado: (2020)

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
por: Beyer, Leonie, et al.
Publicado: (2018)

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers
por: Vasilevskaya, Anna, et al.
Publicado: (2020)

The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
por: Alster, Piotr, et al.
Publicado: (2021)

Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn)
por: Saito, Yuya, et al.
Publicado: (2022)

No Evidence of a Contribution of the Vestibular System to Frequent Falls in Progressive Supranuclear Palsy
por: Goldschagg, Nicolina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kgvohd9fi121517llul36b9dsk